Ryght AI is a technology company specializing in AI-powered solutions for clinical trial site selection and feasibility. Their platform features AI Site Twins, which are digital replicas of every clinical research site worldwide. These AI Site Twins enable sponsors and CROs to make data-driven decisions that reduce costs, compress timelines, and optimize clinical trial operations from site selection through study activation and patient enrollment.

Ryght AI rapidly analyzes study protocols and connects trial sponsors to high-potential research sites anywhere in the world. Their technology streamlines site selection, accelerates site activation, and improves enrollment forecasting accuracy, helping bring therapies to patients faster.

Ryght AI aims to revolutionize the clinical trial process by leveraging advanced AI and machine learning. Their mission is to enhance the efficiency and effectiveness of clinical trials through predictive site selection and continuous optimization of site performance throughout the trial. With a team of industry experts and a strong scientific advisory board, they are committed to transforming how clinical research is conducted worldwide.